Lowering Cholesterol in Patients With Cardiovascular Disease

A recent study showed a discrepancy between the target levels of LDL cholesterol stipulated in European guidelines and the levels achieved in clinical practice.

Related Keywords

Bad Nauheim ,Hessen ,Germany ,Hamburg ,Mannheim ,Baden Wüberg ,German ,Oliver Weing ,Elisabeth Steinhagen Thiessen ,Roland Klingenberg ,Bernd Nowak ,Meeting Of The German Society For Cardiology ,Association Of German Cardiologists ,Thorax Center ,Jena University Hospital In ,Medicine Of The Rostock University Medical Center ,European Society Of Cardiology Atherosclerosis ,Cardiovascular Center Bethanien ,European Society ,European Atherosclerosis Society ,Kerckhoff Heart ,Annual Meeting ,German Society ,Jena University Hospital ,Internal Medicine ,Rostock University Medical Center ,German Social Code ,German Civil ,State Court ,German Cardiologists ,Lipids ,Ipid Management ,Pcsk9 ,Roprotein Convertase Subtilisin Kexin Type 9 ,Cv ,Ardiovascular ,Low Ldl Cholesterol ,Ypobetalipoproteinemia ,Ow Low Density Lipoprotein Cholesterol ,Clinical Guidelines ,Guidelines ,Europe ,European , ,Cardiovascular Disease ,Vd Cardiovascular Disease ,Health Care Economics ,Conomics ,Statin ,Lipid Lowering Drugs ,Rug Lipid Lowering ,Social Determinants Of Health ,